Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00035074 · ClinicalTrials.gov registry record · NA
A Pharmacokinetic Study to Determine the Oral Bioavailability of Methotrexate in Patients With Inflammatory Bowel Disease
A NA study, sponsored by National Center for Research Resources (NCRR).
- Completed
- Registry status
- NA
- Development phase
NCT00035074: Completed NA study, sponsored by National Center for Research Resources (NCRR).
NCT00035074 is a NA study that has completed, run by National Center for Research Resources (NCRR). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00035074, a NA study, has completed, sponsored by National Center for Research Resources (NCRR).
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
Patients with inflammatory bowel disease (IBD) who require methotrexate (MTX)for treatment currently receive this drug by injection. MTX is also available as a pill that can be given by mouth but it is not known how well the drug enters the body in patients with Crohn's disease or ulcerative colitis. This study is being done to compare how much MTX enters the body when the drug is taken by mouth compared to when it is given by injection. If the drug is well absorbed, it may allow patients to receive the drug by mouth.
Interventions
- DRUG Methotrexate
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00035074 record still lists
NCT00035074 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Methotrexate is the first listed.
NCT00035074 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00035074 about?
NCT00035074 is a clinical study titled "A Pharmacokinetic Study to Determine the Oral Bioavailability of Methotrexate in Patients With Inflammatory Bowel Disease". Patients with inflammatory bowel disease (IBD) who require methotrexate (MTX)for treatment currently receive this drug by injection. MTX is also available as a pill that can be given by mouth but it is not known how well the drug enters the body in patients with Crohn's disease or ulcerative colitis...
What is the current status of trial NCT00035074?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00035074?
The interventions under investigation include: Methotrexate (DRUG).
Who is sponsoring clinical trial NCT00035074?
This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.